Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
extension entities : Eli lilly and company save search
Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma
Published: 2023-11-08 (Crawled : 22:00) - prnewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -0.15%
H: 1.69%
C: 1.54%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -0.71%
H: 0.14%
C: -3.81%
biopharma acquire extension
Lilly Announces Extension of Tender Offer to Acquire DICE
Published: 2023-07-25 (Crawled : 12:00) - biospace.com/
DICE | $47.55 0.06% 0.08% 0
|
|
| O: -0.21%
H: 0.15%
C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -0.34%
H: 0.69%
C: -0.05%
acquire extension
Propulsion of Pancreatic Cancer Pipeline as Novel and Extensive 170+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
Published: 2023-01-02 (Crawled : 16:00) - prnewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
| Email alert
Add to watchlist
RCUS 4 | $14.68 0.62% 0.0% 450K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
QLGN | $0.294 -7.55% -8.16% 47K
|
Health Technology
| Email alert
Add to watchlist
BNTX | News | $88.01 1.38% 1.36% 390K
|
Health Technology
| Email alert
Add to watchlist
AGEN A | $5.78 8.85% 7.97% 900K
|
Health Technology
| Email alert
Add to watchlist
MRUS | $40.435 1.57% 1.55% 710K
|
Health Technology
| Email alert
Add to watchlist
GRTX | $0.1909 3.75% 3.61% 670K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
treatment cancer pancreatic
TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases
Published: 2022-03-08 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
treatment disease trex media
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
Published: 2022-03-07 (Crawled : 13:30) - biospace.com/
CNTA | News | $10.0 -5.39% -5.7% 210K
|
Manufacturing
|
| O: -8.81%
H: 10.7%
C: -3.99%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
als
Reify Health Powers Patient Recruitment and Enrollment Across AstraZeneca’s Extensive Breast Cancer Clinical Trial Pipeline
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 1.62%
C: 0.11%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.35%
cancer breast cancer trial enroll health
Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis
Published: 2021-04-06 (Crawled : 23:00) - biospace.com/
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -0.11%
H: 0.51%
C: -1.02%
INCY | $51.92 -0.82% -0.83% 1.8M
|
Health Technology
|
| O: -0.3%
H: 1.07%
C: 0.22%
new drug treatment dermatitis drug baricitinib atopic dermatitis
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.